A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia Post author: Post published:March 1, 2026 Post category: Continue ReadingAutologous Muscle Derived Cells for Treatment of Tongue Dysphagia
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis Post author: Post published:March 1, 2026 Post category: Continue ReadingA Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
CAR-T Long Term Follow Up (LTFU) Study Post author: Post published:March 1, 2026 Post category: Continue ReadingCAR-T Long Term Follow Up (LTFU) Study
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingA Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma Post author: Post published:March 1, 2026 Post category: Continue ReadingA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) Post author: Post published:March 1, 2026 Post category: Continue ReadingAB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma Post author: Post published:March 1, 2026 Post category: Continue ReadingSafety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma Post author: Post published:March 1, 2026 Post category: Continue ReadingHumacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
